Data and Information
HIMSS24
Brenna Loufek, SaMD regulatory affairs manager at Mayo Clinic, discusses her HIMSS24 session on bringing AI-enabled digital health tools built under research into the clinical setting and what she hopes the audience will gain from the discussion.
Dr. Melek Somai, chief technology and product officer at Froedtert & Medical College of Wisconsin Health Network, discusses how Froedtert and Inception Health use genAI, including helping patients with scheduling and navigating healthcare.
Dr. Melek Somai, chief technology and product officer at Froedtert & Medical College of Wisconsin Health Network, relays how genAI is impacting various sectors of healthcare and how harnessing the tech will extend human discovery in medicine.
Alongside generative AI, the large database has been foundational to the development of its latest AI-powered drug discovery system.
The company will offer a customizable version of its Marketplace Search Technology to health plans supporting Medicare beneficiaries.
HIMSS24
Jim St. Clair of the Interoperability Institute and Dr. Paul Tibbits and Dr. Thomas Osborne of the U.S. Dept. of Veterans Affairs discuss how digital twins are used within federal hospital systems and academic universities to boost care.
CitiusTech claims that most genAI proof of concepts is delayed due to the lack of trust.
A survey by The Clinic by Cleveland Clinic revealed nearly four in ten respondents had reservations around seeking a second opinion if the provider used AI diagnostic tools.
The company signed a research contract with the Office of the Director of National Intelligence's Intelligence Advanced Research Projects Activity.
HIMSS24
Kristin Glaza at Oracle Health, Sabrina Matlock at the American Immunization Registry Association and Sarah Finley from the Missouri Department of Health and Senior Services discuss immunization data quality via public-private collaborations.